A carregar...
Hydroxyurea-induced cutaneous squamous cell carcinoma: A case report
BACKGROUND: Hydroxyurea (HU) is a non-alkylating antineoplastic agent that is active in the S-phase of the cell cycle and inhibits the enzyme ribonucleoside reductase. HU is currently used to treat leukemia, sickle cell anemia, psoriasis, and chronic myeloproliferative disorders. Although HU is easy...
Na minha lista:
| Publicado no: | World J Clin Cases |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906572/ https://ncbi.nlm.nih.gov/pubmed/31832413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i23.4091 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|